![The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/05/web-cover-classics-with-logo-medicine-BW-small-jpg-350x250.jpg){kind=logo}
The COVE trial: mRNA-1273 vaccine for preventing COVID-19 [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
Tag: mRNA-1273 vaccine
mRNA-1273 vaccine reduces risk of Covid-19-related outcomes compared to BNT162b2 in U.S. veterans
1. The mRNA-1273 vaccine was shown to reduce the absolute risk of Covid-19-related outcomes in U.S. veterans compared to BNT162b2 ...
#VisualAbstract: Special Report: Vaccines in Development Part 2: Moderna vaccine second to receive emergency use authorization
Section 2: Moderna Vaccine Second to Receive Emergency Use Authorization The FDA Advisory Committee met on December 17, 2020, ultimately ...
mRNA-1273 Covid-19 vaccine exerts potent immunogenic and protective effects in nonhuman primates
1. Administration of mRNA-1273 to rhesus macaques induced ACE2 binding inhibition and neutralizing activity that were orders of magnitude higher ...
mRNA-1273 SARS-CoV-2 vaccine likely effective in nonhuman primates
1. Nonhuman primate vaccination with messenger RNA (mRNA)-1273 induced rapid neutralizing activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ...
COVID-19 mRNA-1273 vaccine safe and immunogenic in phase 1 trial
1. The mRNA-1273 SARS-CoV-2 (COVID-19) vaccine was shown to be safe and immunogenic amongst the 45 COVID-19 negative participants in ...